Note: Ingredients listed on restricted chemical lists
EC/CAS
7647-01-0
Name of the chemical
Hydrochloric acid
Concentration
N/A
EC/CAS
7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
N/A
General Information
Revision date
2020-04-08
Product name
Glycopyrronium Bromide 200 micrograms/mL Injection
1.2.1 Relevant identified uses
Indicated for use in anesthesia as a preoperative antimuscarinic to reduce salivary, tracheobronchial, and pharyngeal secretions; to reduce the volume and free acidity of gastric secretions; and, to block cardiac vagal inhibitory reflexes during induction of anesthesia and intubation. When indicated, glycopyrrolate injection may be used intraoperatively to counteract surgically or drug-induced or vagal reflexes associated arrhythmias. Glycopyrrolate protects against
Manufacturer Name
Sponsor
Icons in SDS
Company Information
company name
Accord Healthcare Pty Ltd
Section 2
Classification (GHS-US)
Not classified
2.2 Label elements
GHS-US Labeling: No labeling applicable
2.3 Other hazards
Refer to patient insert for more information. Exposure may aggravate individuals with pre-existing skin, kidney, liver, and pulmonary disorders.
Ingredient(s) with unknown acute toxicity
No data available
